O Complexo Econômico-Industrial da Saúde no Brasil: formas de articulação e implicações para o SNI em saúde

Abstract

The paper seeks to provide an analysis on the main factors which determine the dynamics of production and innovation in the scope of HEIC. In doing so, it seeks to examine the relation between the health production system and the health innovation system in Brazil.Therefore, health sector is seen as an interdependent economic space that characterizes both an innovation system and a production system, which conjoin enormous potential for knowledge generation, mass consumption and marked presence of the State in the regulation and promotion of activities and innovation.

Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013

“…Também é considerada uma alavanca para atingir metas políticas mais amplas, como desenvolvimento tecnológico e inovação (ALBANO; SPARRO, 2010). O processo de transferência de tecnologia foi adotado pelo governo como estratégia para catch up tecnológico na área de medicamentos, setor onde a dependência externa do país é grande (GADELHA et al, 2013;SORTE JUNIOR, 2012;TIGRE, 2006).…”

Políticas de fomento à ciência, tecnologia e inovação em saúde no Brasil e o lugar da pesquisa clínica

“…The studies of Freeman 2 ,Lundvall 3 , and Nelson 4 , in Costa 5 are considered the origin of this concept. The process leading up to the National Health Innovation System in Brazil included in particular the development of a theoretical framework from which derives the concept for the Economic-Industrial Healthcare Complex 6,7 . This in turn is based on a social-development project, enabling articulation between social inclusion, mass consumption, increased jobs and income, a stronger manufacturing structure, and innovative processes and investments, potentially reducing nation's dependence, which according to Costa It is clear that innovation in healthcare involves a field of excellence, given that it is able to mobilize the ST&I/H infrastructure and articulate with the industrial base to promote its consolidation.…”

Vulnerabilidade do SUS em relação à variação cambial: análise da dinâmica de importações de medicamentos e equipamentos de saúde entre 1996 e 2014

“…One should also highlight the various initiatives involving Science and Technology (S&T) policies of innovative national capacities, and specifically the signature, in the 1990s, of the Trade-Related Aspects of Intellectual Property Rights (Trips) by the members of the World Trade Organization (WTO). The agreement involved the recognition of pharmaceutical patents by a large number of countries, Brazil among them (GADELHA ET AL., 2012). Amid the challenges, it is worth noting the growing competitive pressure associated with generic drugs while patents owned by leading drugs in the market were close to their expiration date.…”

“…In addition, the production carried out by companies located in the national territory still heavily relies on imported inputs of greater technological content, reaching up to 50% in some segments (GADELHA ET AL., 2012).…”